1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc XNAS: BEAM
24.27 0.36 (1.51%)
2.1M
XNAS Volume

XNAS 30 Sep, 2025 4:16 PM (EDT)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 14 analysts

Beam Therapeutics Inc has a share price target of US$ 46, revenue growth forecast of -28.5%, and profit growth estimate of -11.6% for FY25, based on top 14 analyst calls.